Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
Clinical trial NCT02420379 · COMPLETED
Trial details
- NCT number
- NCT02420379
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-30
- Primary completion
- 2018-12-17
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.